Ron Cohen
2008
In 2008, Ron Cohen earned a total compensation of $2M as President and Chief Executive Officer at Acorda Therapeutics, a 216% increase compared to previous year.
Compensation breakdown
| Bonus | $207,410 |
|---|---|
| Option Awards | $840,088 |
| Salary | $459,800 |
| Stock Awards | $495,250 |
| Other | $6,900 |
| Total | $2,009,448 |
Cohen received $840.1K in option awards, accounting for 42% of the total pay in 2008.
Cohen also received $207.4K in bonus, $459.8K in salary, $495.3K in stock awards and $6.9K in other compensation.
Rankings
In 2008, Ron Cohen's compensation ranked 2,425th out of 9,135 executives tracked by ExecPay. In other words, Cohen earned more than 73.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,425 out of 9,135 | 74th |
Division Manufacturing | 878 out of 3,436 | 74th |
Major group Chemicals And Allied Products | 152 out of 815 | 81st |
Industry group Drugs | 88 out of 597 | 85th |
Industry Biological Products, Except Diagnostic Substances | 16 out of 118 | 86th |
Source: SEC filing on April 29, 2011.
Cohen's colleagues
We found three more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2008.
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019